Liquidia Technologies, Inc. (LQDA): Price and Financial Metrics

Liquidia Technologies, Inc. (LQDA): $5.28

0.01 (+0.19%)

POWR Rating

Component Grades














  • LQDA scores best on the Sentiment dimension, with a Sentiment rank ahead of 84.89% of US stocks.
  • LQDA's strongest trending metric is Momentum; it's been moving up over the last 80 days.
  • LQDA's current lowest rank is in the Stability metric (where it is better than 13.39% of US stocks).

LQDA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for LQDA is 0.14 -- better than only 14.17% of US stocks.
  • With a price/sales ratio of 27.74, LIQUIDIA CORP has a higher such ratio than 94.8% of stocks in our set.
  • As for revenue growth, note that LQDA's revenue has grown 91.73% over the past 12 months; that beats the revenue growth of 89.96% of US companies in our set.
  • Stocks that are quantitatively similar to LQDA, based on their financial statements, market capitalization, and price volatility, are KIND, LIDR, RAMP, FROG, and ALKT.
  • Visit LQDA's SEC page to see the company's official filings. To visit the company's web site, go to

LQDA Valuation Summary

  • In comparison to the median Healthcare stock, LQDA's EV/EBIT ratio is 170.53% lower, now standing at -7.3.
  • LQDA's price/sales ratio has moved up 5.3 over the prior 50 months.

Below are key valuation metrics over time for LQDA.

Stock Date P/S P/B P/E EV/EBIT
LQDA 2022-09-09 28.4 3.8 -8.9 -7.3
LQDA 2022-09-08 28.6 3.9 -8.9 -7.4
LQDA 2022-09-07 27.0 3.7 -8.4 -6.9
LQDA 2022-09-06 26.2 3.5 -8.2 -6.6
LQDA 2022-09-02 27.3 3.7 -8.5 -7.0
LQDA 2022-09-01 22.7 3.1 -7.1 -5.5

LQDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LQDA has a Quality Grade of D, ranking ahead of 6.72% of graded US stocks.
  • LQDA's asset turnover comes in at 0.106 -- ranking 153rd of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows LQDA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.106 0.756 -1.103
2021-06-30 0.075 0.771 -1.558
2021-03-31 0.049 0.756 -2.131
2020-12-31 0.011 0.679 -2.776
2020-09-30 0.000 NA -3.022
2020-06-30 0.000 NA -2.692

LQDA Price Target

For more insight on analysts targets of LQDA, see our LQDA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.25 Average Broker Recommendation 1.5 (Moderate Buy)

LQDA Stock Price Chart Interactive Chart >

Price chart for LQDA

LQDA Price/Volume Stats

Current price $5.28 52-week high $8.79
Prev. close $5.27 52-week low $2.60
Day low $4.97 Volume 919,500
Day high $5.35 Avg. volume 1,325,540
50-day MA $5.90 Dividend yield N/A
200-day MA $5.59 Market Cap 339.83M

Liquidia Technologies, Inc. (LQDA) Company Bio

Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.

LQDA Latest News Stream

Event/Time News Detail
Loading, please wait...

LQDA Latest Social Stream

Loading social stream, please wait...

View Full LQDA Social Stream

Latest LQDA News From Around the Web

Below are the latest news stories about LIQUIDIA CORP that investors may wish to consider to help them evaluate LQDA as an investment opportunity.

Liquidia Technologies (LQDA) Initiated with a Sell at Wedbush

In a report released today, Andreas Argyrides from Wedbush initiated coverage with a Sell rating on Liquidia Technologies (LQDA - Research Report) and a price target of $3.00. The company's shares closed last Friday at $5.99.According to TipRanks, Argyrides is an analyst with an average return of -14.8% and a 21.88% success rate. Argyrides covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical, RegenXBio, and Albireo Pharma.Currently, the analyst consensus on Liquidia Technologies is a Moderate Buy with an average price target of $14.00.

Carrie Williams on TipRanks | September 19, 2022

Trade Alert: The CEO & Director Of Liquidia Corporation (NASDAQ:LQDA), Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares

Potential Liquidia Corporation ( NASDAQ:LQDA ) shareholders may wish to note that the CEO & Director, Roger Jeffs...

Yahoo | September 10, 2022

7 Stocks From Insiders’ Weekly Shopping List That Can Make You Rich

Noted investor Peter Lynch once said, “Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” Taking his advice, using TipRanks' Insiders' Hot Stocks tool, we have compiled seven stocks that insiders have been purchasing this week. The purchases were not small either. Insiders bought shares worth over $1 million of each stock. With each of the stocks trading at attractive valuations and impressive upside potential, this can be a great time to invest in them.

Chandrima Sanyal on TipRanks | September 9, 2022

Liquidia (NASDAQ:LQDA) Is Using Debt Safely

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Yahoo | September 8, 2022

Liquidia faces delay for drug launch after ruling in United Therapeutics case

A Morrisville pharmaceutical company is facing a longer regulatory path for its lead asset following a mixed court ruling.

Yahoo | September 6, 2022

Read More 'LQDA' Stories Here

LQDA Price Returns

1-mo -28.07%
3-mo 21.66%
6-mo -23.70%
1-year 83.97%
3-year 33.00%
5-year N/A
YTD 8.42%
2021 65.08%
2020 -30.99%
2019 -80.26%
2018 N/A
2017 N/A

Continue Researching LQDA

Want to see what other sources are saying about Liquidia Technologies Inc's financials and stock price? Try the links below:

Liquidia Technologies Inc (LQDA) Stock Price | Nasdaq
Liquidia Technologies Inc (LQDA) Stock Quote, History and News - Yahoo Finance
Liquidia Technologies Inc (LQDA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6575 seconds.